Skip to main content

Site notifications

Lapatinib film-coated tablet 250 mg product-specific bioequivalence guidance (Draft)

We have adopted this International Scientific Guideline - EMA/CHMP/257298/2018

Last updated

Help us improve the Therapeutic Goods Administration site